Company CVAbout Corona Remedies Ltd 
Corona Remedies Ltd
Mid Cap
Pharmaceuticals & Biotechnology
No Details Available.
Company Coordinates
No Company Details Available
Capital StructureCapital Structure
Present Equity Capital
INR None Cr
Number of Shares
None Cr
Face Value
INR None
Date
Number
of Shares(Cr)
of Shares(Cr)
Equity
Capital (Rs Cr)
Capital (Rs Cr)
Shares Added
Face Value (Rs)
Reason
No Details Available.
ShareholdingShareholding Snapshot
Shareholding Compare (%holding)
Majority shareholders
Promoters
Pledged Promoter Holdings
None
Mutual Funds
Held by 14 Schemes (2.44%)
FIIs
Held by 43 FIIs (1.04%)
Promoter with highest holding
Ankurbhai K Mehta (22.0%)
Highest Public shareholder
Sepia Investments Limited (19.76%)
Individual Investors Holdings
4.83%
Board of Directors
Management
Designation
Remuneration
No Data
Raw MaterialsRaw Materials Dashboard
Raw Materials
Amount(Rs Cr)
% of RM Cost
No Data Available for Raw Material Segmentation
No Data Available
Finished Goods Finished Goods Dashboard
Finished Goods
Amount(Rs Cr)
% of Sales Turnover
No Data Available for Finished Goods Segmentation
No Data Available
Stock DNARevenue and Profits:
Net Sales:
(Quarterly Results - )
Net Profit:
Pharmaceuticals & Biotechnology
INR 8,683 Cr (Mid Cap)
56.00
33
0.00%
-0.01
24.58%
13.74
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
